Megaport (ASX:MP1) see revenue up 10% quarter on quarter

06Apr

Megaport (ASX:MP1) see revenue up 10% quarter on quarter

 

Connectivity company Megaport (ASX:MP1) today reports their quarterly Key Performance Indicators to 31 March 2020 showing revenue for the period was $15.19 million, an increase of 10 per cent quarter on quarter.

In March 2020, Megaport achieved 1,777 customers, generated $5.4 million of Monthly Recurring Revenue.

Megaport expanded its Japan footprint with the addition of two new data centres and integration with two new onramps in Tokyo as well as extension into Osaka with the addition of three new data centres.

Shares in Megaport (ASX:MP1) are trading 1.04 per cent higher at $9.69.
 
Copyright 2020 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

29Sep

Stocks of the Hour: APA, Crown Resorts, Woolworths & Smartgroup

29 Sep 2021 - A snapshot of the stocks on the move, featuring APA Group (ASX:APA), Crown Resorts (ASX:CWN), Woolworths (ASX:WOW), Smartgroup (ASX:SIQ).

Read More
02Sep

Australian Unity Office Fund enters into Scheme Implementation Agreement with Charter Hall and Abacus

02 Sep 2019 - Australian Unity Office Fund (ASX:AOF) has today announced that it has entered into a Scheme Implementation Agreement with Abacus Property Group and Charter Hall Group (Consortium).

Read More
07Apr

EML Payments (ASX:EML) to acquire European open-banking company

07 Apr 2021 - Payment solutions provider EML Payments (ASX:EML) has reached an agreement to acquire open-banking innovator Sentenial.

Read More
26May

BrainChip Holdings (ASX:BRN) enters new joint agreement with car manufacturer

26 May - AI technology company BrainChip Holdings (ASX:BRN) has signed a joint agreement for evaluation of the Akida neural network System-on-Chip (SoC) with The Ford Motor Company.

Read More
01Jul

Telix (ASX:TLX) granted FDA Break Through status for cancer treatment

01 Jul 2020 - Telix Pharmaceuticals (ASX:TLX) reports that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy (BT) designation for Telix’s renal cancer imaging product.

Read More
20Jan

Resolute Mining (ASX:RSG) adds to $US gold hedge book

20 Jan 2020 - Resolute Mining (ASX:RSG) has forward sold an additional 37,200 ounces of gold at an average price of US$1,562 per ounce.

Read More
05May

Qantas (ASX:QAN) to extend flight cancellations to July

05 May 2020 - Qantas (ASX:QAN) is extended flight cancellations for June and July but could restore some services at relatively short notice as restrictions lift.

Read More
04Jul

Stocks of the Hour: icetana, NRW Holdings, Bowen Coking Coal

04 July 2022 - A snapshot of the ASX 200's performance, the best and worst performers, including stocks on the move, featuring icetana (ASX:ICE), NRW Holdings (ASX:NWH) and Bowen Coking Coal (ASX:BCB).

Read More
20Nov

Commbank (ASX:CBA) capital boost following APRA review

20 Nov 2020 - Following the Banking Royal Commission, Commonwealth Bank of Australia (ASX:CBA) introduced a Remedial Action Plan, outlining the steps its board and senior leaders would take to respond to the Inquiry’s 35 recommendations.

Read More
31Mar

DNR Capital: Reporting season wrap-up

31 Mar 2023 - Hear the latest from DNR Capital Chief Investment Officer and PM of the Australian Equities High Conviction Strategy Jamie Nicol as he provides his thoughts on the recent reporting season and where he sees market opportunities in its wake.

Read More